Medical

Active Implantable Medical Devices Market – Size, Share, Growth and Trends Analysis 2018–2026

Seattle, WA, Aug-12, 2018 — / True Industry News / —

Advancements in technology in the product space and new product launches is expected to boost growth of the active implantable medical devices market

The global active implantable medical devices market was valued at US$ 16,721.2 million in 2016 and is expected to witness a robust CAGR of 5.4% over the forecast period (2018–2026).

Active Implantable Medical Devices Market report 2016-2020 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Active Implantable Medical Devices market research report is a professional and in-depth study on the current state of Active Implantable Medical Devices Industry.

The Active Implantable Medical Devices Market research report covers the present scenario and the growth prospects of the global Active Implantable Medical Devices industry for 2016-2020. The report enlists several important factors, starting from the basics to advanced market intelligence which play a crucial part in strategizing.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1126

Medtronic plc was the first company to receive FDA approval for magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy devices (CRT-D), and was also successful in receiving approval from FDA for MR-Conditional Quadripolar CRT-P in May 2017. In 2016, St. Jude Medical launched its first commercial implants of dorsal root ganglion (DRG) stimulation therapy for management of chronic intractable pain in the U.S. Furthermore, Cochlear Limited launched iPhone compatible cochlear implant in July 2017. Abbott announced European CE mark approval for world’s first smartphone compatible Confirm Rx insertable cardiac monitor in October 2017.

Key Vendors of Active Implantable Medical Devices Market: Some major players operating in the active implantable medical devices market are Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott Laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL.

Active Implantable Medical Devices market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

Regions of Active Implantable Medical Devices market:

• Americas

• APAC

• EMEA

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1126

Purchase

In the end, the report makes some important proposals for a new project of Active Implantable Medical Devices Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2016-2020 global Active Implantable Medical Devices industry covering all important parameters.

Active Implantable Medical Devices driver

Active Implantable Medical Devices challenge

Active Implantable Medical Devices trend

Strong competition in the market spurs the demand for continuous development from supply as well as demand side as manufacturers thrive to stay competitive in the market and customers remain on the lookout for the alternatives boosting the development rate in active implantable medical devices market driving growth of the global active implantable medical devices market

Implantable Neurostimulators product type segment is expected to show significant growth owing to increasing application in management of chronic pain diseases

Asia Pacific region is expected to show significant growth owing to multiple product launches by major players such as launch of Edora pacemakers by Biotronik in Japan in 2017

According to WHO, 31% (about 17.7 million) of all global deaths were due to cardiovascular diseases (CVDs) and this number is expected to grow further as aging population, which are more prone to CVDs is growing. Growing prevalence of cardiovascular diseases, which can be monitored or treated by devices such as pacemakers and ICDs, is expected to be the major factors driving growth of the global active implantable medical devices market over the forecast period

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1126

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *

Close